Matches in Nanopublications for { ?s ?p "[SEMG-1 is expressed in nearly half of patients with early CLL and may be a target for further investigations into its use for immunotherapy of early CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP348001.RAKKeLGBkqczLavHfpUwo9uNLltIp2OfyNhyJIEdeuU3Q130_assertion description "[SEMG-1 is expressed in nearly half of patients with early CLL and may be a target for further investigations into its use for immunotherapy of early CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348001.RAKKeLGBkqczLavHfpUwo9uNLltIp2OfyNhyJIEdeuU3Q130_provenance.
- NP690324.RAbMVRxFjkMz6a5LOEMMtcc4Ty9xuEHFN3blG_-wD837g130_assertion description "[SEMG-1 is expressed in nearly half of patients with early CLL and may be a target for further investigations into its use for immunotherapy of early CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690324.RAbMVRxFjkMz6a5LOEMMtcc4Ty9xuEHFN3blG_-wD837g130_provenance.
- assertion description "[SEMG-1 is expressed in nearly half of patients with early CLL and may be a target for further investigations into its use for immunotherapy of early CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_assertion description "[SEMG-1 is expressed in nearly half of patients with early CLL and may be a target for further investigations into its use for immunotherapy of early CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.